Senti Biosciences Issues $4.0 Million in Senior Secured Convertible Notes

Filing content

The company issued $4.0 million in senior secured convertible notes under a previously announced purchase agreement and is proceeding with shareholder meetings regarding potential transactions involving up to $60.0 million in contingent value rights.